Evidence map›Paper›PMID 34593792›Full record

ArticleNature communications2021

Wdr1 and cofilin are necessary mediators of immune-cell-specific apoptosis triggered by Tecfidera.

Jesse R Poganik, Kuan-Ting Huang, Saba Parvez, Yi Zhao, Sruthi Raja, Marcus J C Long, Yimon Aye

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Function-guided proximity mapping unveils electrophilic-metabolite sensing by proteins not present in their canonical locales.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Jesse R PoganikSwiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-3098-8550
Kuan-Ting HuangSwiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.
Saba ParvezDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
Yi ZhaoBayRay Innovation Center, Shenzhen Bay Laboratory (SZBL), Guangdong, China.
Sruthi RajaSwiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.
Marcus J C LongUniversity of Lausanne (UNIL), Lausanne, Switzerland. marcusjohncurtis.long@unil.ch.ORCID http://orcid.org/0000-0002-0343-9671
Yimon AyeSwiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland. yimon.aye@epfl.ch.ORCID http://orcid.org/0000-0002-1256-4159
École Polytechnique Fédérale de Lausanne · CHBrigham and Women's Hospital · USShenzhen Bay Laboratory · CNUniversity of Lausanne · CHUniversity of Utah · US

Funding

Predoctoral Training Program in Chemistry & BiologyT32GM008720 · NIGMS · UNIVERSITY OF CHICAGO · PI PICCIRILLI, JOSEPH ANTHONY · 1999 to 2020
$4.7M
Acquisition of a Hybrid Quadrupole Time of Flight LC-MS/MS System for the CornellS10OD017992 · OD · CORNELL UNIVERSITY · PI ZHANG, SHENG · 2014 to 2014
$600k
American Heart Association-American Stroke Association 17PRE33670395NIGMS NIH HHS T32 GM008720NIH HHS S10 OD017992
6 · The paper itself

Abstract

Despite the emerging importance of reactive electrophilic drugs, deconvolution of their principal targets remains difficult. The lack of genetic tractability/interventions and reliance on secondary validation using other non-specific compounds frequently complicate the earmarking of individual binders as functionally- or phenotypically-sufficient pathway regulators. Using a redox-targeting approach to interrogate how on-target binding of pleiotropic electrophiles translates to a phenotypic output in vivo, we here systematically track the molecular components attributable to innate immune cell toxicity of the electrophilic-drug dimethyl fumarate (Tecfidera®). In a process largely independent of canonical Keap1/Nrf2-signaling, Keap1-specific modification triggers mitochondrial-targeted neutrophil/macrophage apoptosis. On-target Keap1-ligand-engagement is accompanied by dissociation of Wdr1 from Keap1 and subsequent coordination with cofilin, intercepting Bax. This phagocytic-specific cell-killing program is recapitulated by whole-animal administration of dimethyl fumarate, where individual depletions of the players identified above robustly suppress apoptosis.

Indexed as

Actin Depolymerizing FactorsAnimalsAnimals, Genetically ModifiedApoptosisDimethyl FumarateEmbryo, MammalianEmbryo, NonmammalianGene Knockdown TechniquesHEK293 CellsHumansImmunity, InnateImmunosuppressive AgentsKelch-Like ECH-Associated Protein 1MacrophagesMiceMicrofilament ProteinsActin Depolymerizing FactorsDimethyl FumarateImmunosuppressive AgentsKEAP1 protein, humanKelch-Like ECH-Associated Protein 1Microfilament ProteinsWDR1 protein, human

Identifiers

PMID34593792
PMCPMC8484674
OpenAlexW3201756606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.